Billionaire Israel Englander's 2 Biggest Bets Are on the S&P 500, and He Just Bought More

Millennium Management disclosed large S&P 500 ETF positions, adding 1.5M shares of iShares Core S&P 500 ETF (IVV) and 4.2M shares of SPDR S&P 500 ETF (SPY) in Q2 via its 13F. IVV and SPY together account for nearly 10% of the fund’s portfolio, with sector exposures spread broadly (tech largest at ~17%). The piece highlights IVV’s lower expense ratio (0.03% vs 0.095% for SPY) as the main differentiator, implying modestly favorable cost efficiency rather than a major market-moving development.

Analysis

This is less a bullish call on passive vehicles than a window into how elite multi-manager capital is actually run: beta is increasingly outsourced to cheap, highly liquid wrappers, while the real research budget is reserved for idiosyncratic singles like NVDA and NSC. That matters because it reinforces a structural bid for cap-weighted mega-caps and makes concentration self-reinforcing; the marginal dollar of risk capital still gravitates toward the most liquid names, not the cheapest or smallest. Over 6-18 months, that dynamic can keep the index heavy in a few winners even if breadth stays mediocre.

The more interesting split is liquidity versus economics. SPY’s edge is not return, it is tradability; IVV’s edge is carrying cost. That means SPY should keep winning in periods of higher hedging demand and volatile macro tape, while IVV should quietly keep taking core assets from longer-horizon allocators. For State Street, the risk is that SPY remains a great trading franchise but not a high-growth AUM story if fee compression persists elsewhere. For NVDA, the second-order effect is supportive: if multi-managers keep parking beta in ETFs, their remaining active risk budget is even more likely to cluster around liquid winners like NVDA, amplifying relative strength on dips.

Consensus may overread this as a broad endorsement of index investing; the real signal is more mundane and more actionable: sophisticated capital is de-risking process, not conviction. The thesis breaks if volatility compresses and ETF options activity fades, because then SPY’s liquidity premium shrinks and IVV’s lower fee should dominate. Conversely, a vol spike or macro shock would widen the trading premium back toward SPY and make the ETF complex more important than the underlying stock picks.

Key Decisions for Investors

• Use SPY, not IVV, for any 1-3 month macro hedge or event-driven beta expression; the liquidity premium is the point. Falsify if VIX stays below ~14 and ETF option turnover normalizes.
• Stay long NVDA on pullbacks versus a market hedge if you want to express the concentration trade: the article reinforces that incremental active risk is still being recycled into mega-cap winners. Risk/reward improves if NVDA holds relative strength into the next earnings cycle; cut if it underperforms SPY by ~8-10% on a rolling 1-month basis.
• Do not chase STT on this headline alone. It is a watch item for ETF flow and options-volume sensitivity, not a clean fundamental re-rate. Consider only if SPY trading volumes and creation/redemption activity keep rising over the next 1-3 months.
• For long-term core beta, prefer IVV over SPY on cost grounds; the edge is small per year but compounds. This is an allocation decision, not a near-term trade.